Redefining wellness apps in the era of compulsive design
Wellness app funding is beginning to favor studios that prioritise user wellbeing over screen time, backing habit formation apps that aim to become useful daily tools instead of addictive digital escapes. This shift responds to a world where, according to DataReportal 2025, the average person spends 5 hours and 16 minutes a day on a smartphone. Rocapine has stepped into this debate with a clear stance: apps should “hold instead of hook,” becoming part of routines because they support users, not because they engineer compulsion. Its portfolio spans women’s health, behaviour change and nutrition, and each product is framed as an antidote to extractive engagement loops. In this context, the studio’s new funding round is more than a capital injection; it is a signal that investors now see wellbeing-focused engagement as an investable design philosophy rather than a niche experiment.
Inside Rocapine’s €11.2M Series A and studio model
Rocapine secured a €11.2 million (USD 13 million, approx. RM61.9 million) Series A round led by Educapital, with participation from Daphni, Ring Capital, Centre Court Capital, Athletico Ventures and Better Angle, plus founders from Alan, Yubo, Opal, Photoroom, Madbox and The Sandbox. Founded in late 2024 by Stanislas Marchand, Jean-Gabriel Boinot-Tramoni and Sammy Teillet, the studio operates as an AI wellness platform that builds, tests and scales many apps rather than betting on a single product. According to EU-Startups, Rocapine has reached €5.1 million (approx. RM26.2 million) in ARR over nine months and more than 2.5 million downloads, with 70% of revenue coming from the US. One app reportedly hit €863.6k (approx. RM4.4 million) in ARR 16 days after launch, proof that “time well spent” can be commercially viable.
From ‘hooked’ to ‘held’: a new app engagement ethics
Rocapine’s philosophy challenges the dominant playbook of attention-maximising design. Instead of push notifications tuned to trigger anxiety or endless feeds built for habit loops, its habit formation apps aim to “hold instead of hook” by tying engagement to clear benefits such as better sleep, healthier routines or reduced compulsive behaviour. The company says it is inverting the mobile gaming growth playbook: still using fast iteration, AI-native development and performance marketing, but optimising for “time well spent” instead of time-on-screen. This is app engagement ethics translated into product metrics. Success is not counted by hours captured, but by how well the app supports a desired behaviour. That reframing matters in categories like women’s health (Harmony), daily routines (That Girl) and addiction support (Unchaind), where trust and long-term adherence are more important than daily active user streaks.
How AI-driven testing powers healthier habit formation
The heart of Rocapine’s AI wellness platform is a high-velocity publisher model. Rather than incubating a single flagship, the studio plans to test up to 400 apps in a year, often in partnership with independent developers. AI tools help generate, localise and refine product ideas, speeding up everything from onboarding flows to content recommendations. When real-world data shows a concept resonates, Rocapine can personalise the experience and scale the app quickly. Crucially, this AI layer is pointed at sustainable habit formation, not compulsion: the goal is to fit into morning routines, sleep hygiene or recovery programs without nudging users into mindless sessions. This approach turns data-driven optimisation into a tool for wellbeing, aligning business incentives with outcomes such as consistency, completion of healthy actions and gradual reduction of harmful behaviours.
Wellness app funding as an emerging investment thesis
Rocapine’s round underlines how wellness app funding is coalescing into a distinct category, separate from generic consumer or digital health bets. Investors like Educapital and Daphni are backing studios that mix the distribution skills of mobile gaming with a clear commitment to user wellbeing. According to Tech.eu, Rocapine’s early performance—multiple hits, cracked distribution and meaningful revenue in under a year—was central to the investment case. That traction suggests there is strong demand for alternatives to engagement-first platforms, especially in markets such as women’s health, mental health and behaviour change. If Rocapine can turn its early successes into category leaders while holding the line on ethical engagement, it may set a template for future wellness-focused studios: AI-native portfolio builders that earn on the back of healthier habits, not attention drained from users’ lives.
